Bibliographie (2530)
Populational study in France did not show an increased incidence of acute myocardial infarction, stroke, and pulmonary embolism following the Pfizer vaccine.
mardi, 23 novembre 2021 10:02 Écrit par Zouhair SouissiMyocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older – JAMA
The post Populational study in France did not show an increased incidence of acute myocardial infarction, stroke, and pulmonary embolism following the Pfizer vaccine. appeared first on Links Medicus.
![[Preprint] Systematic Review: Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease – “effectiveness against COVID-19 severe disease remained high (>70%) in most studies in the six months after full vaccination, although](/media/k2/items/cache/758dc7ab63677117467388c3b99fce90_L.jpg)
[Preprint] Systematic Review: Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease – “effectiveness against COVID-19 severe disease remained high (>70%) in most studies in the six months after full vaccination, although
mardi, 23 novembre 2021 10:02 Écrit par Zouhair SouissiDuration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease: Results of a Systematic Review and Meta-Regression – Preprints with The Lancet – SSRN Related: Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine. China’s COVID vaccines have been crucial — now immunity is waning. [Preprint] Breakthrough SARS-CoV-2 infections in 620,000 U.S. Veterans, February 1, 2021 to […]
The post [Preprint] Systematic Review: Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease – “effectiveness against COVID-19 severe disease remained high (>70%) in most studies in the six months after full vaccination, although it did decrease some (on average, 8-10 percentage points) between one and six months after full vaccination”. appeared first on Links Medicus.
M-A: Colchicine doesn’t lessen COVID-19 severity or stave off risk of death.
mardi, 23 novembre 2021 10:02 Écrit par Zouhair SouissiNews release: Gout drug colchicine doesn’t lessen COVID-19 severity or stave off risk of death – BMJ Original Study: Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials – RMD Open Related: RECOVERY Trial: In patients admitted to hospital with COVID-19, Colchicine did not reduce 28-day mortality, duration of hospital stay, […]
The post M-A: Colchicine doesn’t lessen COVID-19 severity or stave off risk of death. appeared first on Links Medicus.
Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark – “The IFR was low for people younger than 51 years without comorbidity during the two waves (c
lundi, 22 novembre 2021 02:38 Écrit par Zouhair SouissiEstimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark – The Journal of Infectious Diseases Commentary on Twitter New in JID: A study in Denmark found that the SARS-CoV-2 infection fatality rate was low for people younger than 51 and […]
The post Estimation of SARS-CoV-2 infection fatality rate by age and comorbidity status using antibody screening of blood donors during the COVID-19 epidemic in Denmark – “The IFR was low for people younger than 51 years without comorbidity during the two waves (combined IFR = 3.36 per 100,000 infections)”. appeared first on Links Medicus.
M-A: Convalescent plasma does not reduce mortality in COVID-19.
lundi, 22 novembre 2021 02:38 Écrit par Zouhair SouissiAssociation between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials – BMC Infectious Diseases Related: RCT: Another study shows convalescent plasma does not improve outcomes in critically ill patients with Covid-19. RCT: Convalescent plasma does not improve outcomes and may be harmful to hospitalized patients with […]
The post M-A: Convalescent plasma does not reduce mortality in COVID-19. appeared first on Links Medicus.
Is Delta the last Covid ‘super variant’?
lundi, 22 novembre 2021 02:38 Écrit par Zouhair SouissiIs Delta the last Covid ‘super variant’? – The Guardian
The post Is Delta the last Covid ‘super variant’? appeared first on Links Medicus.
Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research – “The two randomized controlled trials indicate superiority of non-invasive ventilation over high-flow nasal
lundi, 22 novembre 2021 02:38 Écrit par Zouhair SouissiNon-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research – The Lancet Respiratory Medicine Related: [Preprint] RCT: non-invasive respiratory strategies in acute respiratory failure in patients with COVID-19 – CPAP reduced the composite outcome of intubation or death within 30 days; high-flow nasal oxygenation was not associated […]
The post Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research – “The two randomized controlled trials indicate superiority of non-invasive ventilation over high-flow nasal oxygen in reducing the need for intubation”. appeared first on Links Medicus.
EuGMS Guidance: Management of post-acute COVID-19 patients in geriatric rehabilitation.
lundi, 22 novembre 2021 02:38 Écrit par Zouhair SouissiManagement of post-acute COVID-19 patients in geriatric rehabilitation: EuGMS guidance – European Geriatric Medicine Related: Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians. Global surveillance, research, and collaboration needed to improve understanding and management of long COVID. Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief […]
The post EuGMS Guidance: Management of post-acute COVID-19 patients in geriatric rehabilitation. appeared first on Links Medicus.
United States FDA clears COVID vaccine boosters for all adults over 18 – Pfizer & Moderna 6 months after second jab.
lundi, 22 novembre 2021 02:38 Écrit par Zouhair SouissiUnited States FDA Clears COVID Vaccine Boosters for All Adults Over 18 – Pfizer & Moderna 6 Months After Second Jab – Health Policy Watch See also: FDA expands emergency authorization for Covid-19 booster shots to all adults – STAT FDA, CDC advisors approve COVID boosters for all US adults – CIDRAP FDA Approves Both […]
The post United States FDA clears COVID vaccine boosters for all adults over 18 – Pfizer & Moderna 6 months after second jab. appeared first on Links Medicus.
WHO global report on trends in prevalence of tobacco use 2000-2025.
vendredi, 19 novembre 2021 12:06 Écrit par Zouhair SouissiWHO global report on trends in prevalence of tobacco use 2000-2025, fourth edition – World Health Organization News Release: Tobacco use falling: WHO urges countries to invest in helping more people to quit tobacco – World Health Organization Commentary on Twitter Tobacco use is falling by 5⃣ million people per year ? WHO global […]
The post WHO global report on trends in prevalence of tobacco use 2000-2025. appeared first on Links Medicus.
![[Preprint] M-A: Inhaled corticosteroids in COVID-19 outpatients.](/media/k2/items/cache/9489e6c11889fcb275044d14dda99d24_XS.jpg)